Detalles de la búsqueda
1.
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Br J Haematol
; 177(2): 243-253, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220479
2.
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
Br J Haematol
; 176(3): 412-420, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27982425
3.
Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Br J Haematol
; 175(5): 892-903, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27861736
4.
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma.
Haematologica
; 96(4): 567-73, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21173095
5.
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
Am J Hematol
; 86(1): 25-30, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21120861
6.
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites.
Blood Adv
; 4(7): 1407-1418, 2020 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271900
7.
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Clin Lymphoma Myeloma Leuk
; 18(2): 114-124.e2, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29352719
8.
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study.
Leuk Lymphoma
; 59(10): 2327-2335, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29415595
9.
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
EJHaem
; 4(1): 301-304, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819162
10.
Treatment of Peripheral T-Cell Lymphoma in Community Settings.
Clin Lymphoma Myeloma Leuk
; 17(6): 354-361, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622960
11.
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.
Blood Adv
; 1(25): 2433-2443, 2017 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296893
12.
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
J Clin Oncol
; 33(23): 2516-22, 2015 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26124482
13.
Follicular lymphoma in the United States: first report of the national LymphoCare study.
J Clin Oncol
; 27(8): 1202-8, 2009 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19204203
Resultados
1 -
13
de 13
1
Próxima >
>>